Free Trial
NASDAQ:INM

InMed Pharmaceuticals (INM) Stock Price, News & Analysis

InMed Pharmaceuticals logo
$2.75 -0.07 (-2.48%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$2.73 -0.02 (-0.73%)
As of 07/11/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About InMed Pharmaceuticals Stock (NASDAQ:INM)

Key Stats

Today's Range
$2.69
$2.81
50-Day Range
$2.28
$3.87
52-Week Range
$1.72
$15.70
Volume
82,658 shs
Average Volume
1.01 million shs
Market Capitalization
$3.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

InMed Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

INM MarketRank™: 

InMed Pharmaceuticals scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for InMed Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InMed Pharmaceuticals is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InMed Pharmaceuticals is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InMed Pharmaceuticals has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about InMed Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    18.13% of the float of InMed Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    InMed Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InMed Pharmaceuticals has recently increased by 555.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    InMed Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    InMed Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.13% of the float of InMed Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    InMed Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InMed Pharmaceuticals has recently increased by 555.62%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    InMed Pharmaceuticals has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for InMed Pharmaceuticals this week, compared to 0 articles on an average week.
  • Search Interest

    12 people have searched for INM on MarketBeat in the last 30 days. This is an increase of 140% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InMed Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.43% of the stock of InMed Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 20.12% of the stock of InMed Pharmaceuticals is held by institutions.

  • Read more about InMed Pharmaceuticals' insider trading history.
Receive INM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

INM Stock News Headlines

InMed Pharmaceuticals Secures $5M in Private Placement
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

INM Stock Analysis - Frequently Asked Questions

InMed Pharmaceuticals' stock was trading at $4.74 at the beginning of the year. Since then, INM stock has decreased by 42.0% and is now trading at $2.75.

InMed Pharmaceuticals Inc. (NASDAQ:INM) announced its quarterly earnings data on Monday, May, 12th. The company reported ($1.94) earnings per share for the quarter. The company earned $1.26 million during the quarter. InMed Pharmaceuticals had a negative net margin of 168.87% and a negative trailing twelve-month return on equity of 107.93%.

InMed Pharmaceuticals's stock reverse split on the morning of Wednesday, September 7th 2022.The 1-25 reverse split was announced on Wednesday, September 7th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of INM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InMed Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), Broadcom (AVGO), Tesla (TSLA) and PayPal (PYPL).

Company Calendar

Last Earnings
5/12/2025
Today
7/12/2025
Next Earnings (Estimated)
9/29/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:INM
CIK
1728328
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($12.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.68 million
Net Margins
-168.87%
Pretax Margin
-168.71%
Return on Equity
-107.93%
Return on Assets
-82.97%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
3.49
Quick Ratio
3.04

Sales & Book Value

Annual Sales
$4.60 million
Price / Sales
0.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$20.64 per share
Price / Book
0.13

Miscellaneous

Outstanding Shares
1,210,000
Free Float
1,190,000
Market Cap
$3.33 million
Optionable
Not Optionable
Beta
0.30
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:INM) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners